type_of_cancer: mixed
cancer_study_identifier: summit_2018
name: SUMMIT (Nature, 2018)
short_name: Neratinib Basket Study
description: Findings of a multi-histology, genomically selected, 'basket' study utilizing the pan-HER kinase inhibitor neratinib.
citation: Hyman et al. Nature 2018
pmid: 29420467
